Diabetic retinopathy(OM Pharma)(Diabetic retinopathy(OM Pharma)) - 在研适应症：糖尿病性视网膜病变_专利_临床

概要

基本信息

药物类型

化学药

别名-

靶点-

作用方式-

作用机制-

治疗领域

心血管疾病内分泌与代谢疾病眼部疾病

在研适应症

糖尿病性视网膜病变

非在研适应症-

原研机构

OM Pharma SA

在研机构

OM Pharma SA

非在研机构-

最高研发阶段临床前

首次获批日期-

最高研发阶段(中国)-

特殊审评-

关联

2

项与 Diabetic retinopathy(OM Pharma) 相关的临床试验

NCT03911323

/ Unknown statusN/AIIT

A Prospective Clinical Study on the Real-world Diagnostic Effectiveness of Artificial Intelligence Algorithm in Diabetic Retinopathy Screening

Recently, artificial intelligence algorithm has made great progress in the prediction of diabetic retinopathy based on fundus images，showing very high sensitivity and specificity. However，the real-world diagnosis effectiveness of deep learning model is still unclear.
This study is designed to evaluate the clinical efficacy of such an algorithm in detecting referable diabetic retinopathy.

开始日期2018-10-01

申办/合作机构

深圳市第二人民医院

NCT03572699

/ Unknown statusN/A

Simple, Mobile-based Artificial Intelligence AlgoRithms in the Detection of Diabetic ReTinopathy (SMART) Study

This is an observational cross sectional study aimed to evaluate the performance of the artificial intelligence algorithm in detecting any grade of diabetic retinopathy using retinal images from patients with diabetes.

开始日期2018-07-11

申办/合作机构